Stonegate Capital Partners announced the initiation of coverage on Viemed Healthcare, Inc. (NASDAQ: VMD), a leading U.S. provider of in-home post-acute respiratory care. The firm's analysis underscores Viemed's specialization in non-invasive ventilation (NIV) for patients with COPD and chronic respiratory failure, delivered through a clinician-driven, high-touch model that integrates respiratory therapists, proprietary clinical workflows, and continuous patient monitoring. This approach aims to improve patient outcomes while reducing the total cost of care.
While ventilation remains the core of Viemed's business, the company has successfully diversified into complementary services such as sleep therapy and resupply, oxygen therapy, staffing, and maternity care. This diversification has created a more resilient and scalable platform, contributing to 15 consecutive quarters of organic growth. Stonegate highlights the company's strong full-year guidance, which implies approximately 20% year-over-year revenue growth and EBITDA margins of around 22%.
The initiation of coverage by Stonegate Capital Partners, a leading capital markets advisory firm, brings increased visibility to Viemed's growth trajectory and market position. For more details, the full announcement is available here. Stonegate Capital Partners provides investor relations, equity research, and institutional investor outreach services for public companies, while its affiliate Stonegate Capital Markets offers investment banking services. This coverage note is distributed by Reportable, Inc.
